Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNASDAQ:POCINASDAQ:PYPDNASDAQ:SSKN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.76-10.7%$2.90$1.75▼$8.44$3.54M1.89201,077 shs66,445 shsPOCIPrecision Optics$4.67-2.7%$4.38$3.47▼$6.59$35.82M0.2115,385 shs2,176 shsPYPDPolyPid$3.41-0.6%$2.82$2.30▼$4.49$34.75M1.25120,284 shs248,539 shsSSKNSTRATA Skin Sciences$2.26+0.4%$2.54$2.10▼$3.80$9.43M0.712,995 shs3,852 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-10.66%-33.31%-45.65%-41.11%-57.90%POCIPrecision Optics-2.67%-1.43%+1.13%+3.82%-24.40%PYPDPolyPid-0.58%+4.28%+17.59%+15.44%-23.71%SSKNSTRATA Skin Sciences+0.44%-7.00%-14.39%-15.70%-25.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical3.0892 of 5 stars3.55.00.00.02.50.01.3POCIPrecision Optics0.3061 of 5 stars0.03.00.00.01.90.80.0PYPDPolyPid3.1159 of 5 stars3.65.00.00.03.11.70.0SSKNSTRATA Skin Sciences2.8258 of 5 stars3.53.00.00.01.91.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$56.003,081.82% UpsidePOCIPrecision Optics 0.00N/AN/AN/APYPDPolyPid 3.20Buy$11.25229.91% UpsideSSKNSTRATA Skin Sciences 3.00Buy$6.00165.49% UpsideCurrent Analyst Ratings BreakdownLatest SSKN, AEMD, POCI, and PYPD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$11.00 ➝ $13.006/5/2025PYPDPolyPidRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$9.006/2/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy$11.004/14/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.00(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K6.21N/AN/A$2.19 per share0.80POCIPrecision Optics$17.63M2.03N/AN/A$1.49 per share3.14PYPDPolyPidN/AN/AN/AN/A$0.75 per shareN/ASSKNSTRATA Skin Sciences$33.62M0.28N/AN/A$3.65 per share0.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$12.64N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)POCIPrecision Optics-$2.95M-$0.89N/A∞N/A-21.46%-39.17%-22.93%N/APYPDPolyPid-$29.02M-$4.30N/A∞N/AN/A-624.10%-129.28%8/13/2025 (Estimated)SSKNSTRATA Skin Sciences-$10.83M-$2.27N/AN/AN/A-28.72%-69.33%-17.55%8/13/2025 (Estimated)Latest SSKN, AEMD, POCI, and PYPD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q4 2025AEMDAethlon Medical-$0.13N/AN/AN/AN/AN/A5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 million5/14/2025Q1 2025PYPDPolyPid-$0.80-$0.70+$0.10-$0.70N/AN/A5/14/2025Q1 2025SSKNSTRATA Skin Sciences-$0.56-$0.58-$0.02-$0.58$7.28 million$6.81 million3/27/2025Q4 2024SSKNSTRATA Skin Sciences-$0.40-$1.13-$0.73-$1.13$9.03 million$33.56 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/APYPDPolyPidN/AN/AN/AN/AN/ASSKNSTRATA Skin SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80POCIPrecision Optics0.171.220.62PYPDPolyPid0.081.311.00SSKNSTRATA Skin Sciences1.621.130.94Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%POCIPrecision Optics13.71%PYPDPolyPid26.47%SSKNSTRATA Skin Sciences32.43%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%POCIPrecision Optics16.30%PYPDPolyPid24.70%SSKNSTRATA Skin Sciences39.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.01 million14.30 millionNo DataPOCIPrecision Optics807.67 million5.33 millionNot OptionablePYPDPolyPid8010.19 million7.67 millionNo DataSSKNSTRATA Skin Sciences1204.17 million2.54 millionNot OptionableSSKN, AEMD, POCI, and PYPD HeadlinesRecent News About These CompaniesSTRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory DiseasesMay 21, 2025 | nasdaq.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comSTRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comSTRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 14, 2025 | globenewswire.com3SSKN : A Peek at Strata Skin Sciences's Future EarningsMay 13, 2025 | benzinga.comStrata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 13, 2025 | finance.yahoo.comSTRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYCMay 11, 2025 | msn.comSTRATA Skin Sciences to Announce Q1 2025 Financial Results and Host Investor CallMay 11, 2025 | msn.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 9, 2025 | seekingalpha.comSTRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global ConferenceMay 8, 2025 | globenewswire.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 7, 2025 | globenewswire.comStrata Skin Sciences price target lowered to $14 from $16 at LadenburgMarch 31, 2025 | markets.businessinsider.comEarnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10%March 29, 2025 | uk.investing.comSTRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 29, 2025 | finance.yahoo.comSTRATA SKIN SCIENCES Earnings Results: $SSKN Reports Quarterly EarningsMarch 29, 2025 | nasdaq.comStrata Skin Sciences (SSKN) Gets a Buy from Maxim GroupMarch 29, 2025 | markets.businessinsider.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comSTRATA Skin Sciences Reports Strong Q4 Growth and Strategic ProgressMarch 29, 2025 | msn.comQ4 2024 STRATA Skin Sciences Inc Earnings CallMarch 28, 2025 | finance.yahoo.comStrata Skin Sciences reports Q4 EPS ($1.18), consensus (40c)March 28, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSSKN, AEMD, POCI, and PYPD Company DescriptionsAethlon Medical NASDAQ:AEMD$1.76 -0.21 (-10.66%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.80 +0.03 (+1.99%) As of 06/13/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Precision Optics NASDAQ:POCI$4.66 -0.14 (-2.92%) As of 06/13/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.PolyPid NASDAQ:PYPD$3.41 -0.02 (-0.58%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$3.38 -0.03 (-0.88%) As of 06/13/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.STRATA Skin Sciences NASDAQ:SSKN$2.26 +0.01 (+0.44%) Closing price 06/13/2025 03:56 PM EasternExtended Trading$2.12 -0.14 (-5.97%) As of 06/13/2025 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
